AIG SPECIALTY INSURANCE COMPANY v. THERMO FISHER SCIENTIFIC, INC.

CourtDistrict Court, D. New Jersey
DecidedJune 29, 2021
Docket2:20-cv-13046
StatusUnknown

This text of AIG SPECIALTY INSURANCE COMPANY v. THERMO FISHER SCIENTIFIC, INC. (AIG SPECIALTY INSURANCE COMPANY v. THERMO FISHER SCIENTIFIC, INC.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
AIG SPECIALTY INSURANCE COMPANY v. THERMO FISHER SCIENTIFIC, INC., (D.N.J. 2021).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

AIG SPECIALTY INSURANCE COMPANY, Case No. 20–cv–13046–CCC–ESK Plaintiff, v. OPINION THERMO FISHER SCIENTIFIC, INC., et al., Defendants.

KIEL, U.S.M.J. THIS MATTER is before the Court on plaintiff AIG Specialty Insurance Company’s application to sever and stay defendants Thermo Fisher Scientific Inc. and Fisher Scientific Company L.L.C.’s (collectively, Fisher Entities) 1 counterclaim for bad faith (Application). (ECF No. 40.) The Fisher Entities filed an opposition (ECF No. 43), AIG filed a reply in further support of the Application (ECF No. 47), and the Fisher Entities filed a sur-reply in further opposition to the Application (ECF No. 49). A hearing on the Application and related submissions was held on March 15, 2021 (ECF No. 51), and the parties thereafter filed supplemental letters (ECF Nos. 52, 53). For the following reasons, the Application is GRANTED. BACKGROUND This matter is an insurance coverage dispute. (ECF Nos. 32, 37.) In the first amended complaint, AIG disputes the Fisher Entities’ claimed entitlement

1 According to the amended complaint, “[t]hrough a 2006 merger by and between Thermo Electron Corporation and Fisher Scientific’s parent company, [defendant] Fisher Scientific operates as a wholly-owned subsidiary of Fisher Scientific International LLC, which is wholly owned by [defendant] Thermo Fisher.” (ECF No. 32 ¶ 17.) to “insurance coverage under an [AIG] policy to address contamination of groundwater” in the Westmoreland Well Field (Well Field), which supplies drinking water to the Borough of Fair Lawn, New Jersey (Borough). (ECF No. 32 ¶ 1.) The Fisher Entities’ facility (Facility), located near the Well Field (id. ¶ 25), has been the subject of environmental investigation and remediation for several decades. (Id. pp. 5–15; ECF No. 37 pp. 21–31; ECF No. 40 p. 1.) Under a Consent Order with the United States Environmental Protection Agency (Agency), Fisher Scientific Company L.L.C. (Fisher Scientific) agreed to undertake remediation and upgrade the Borough’s water treatment plant at a net present cost of $19,500,000 (Remediation Costs).2 (ECF No. 32 ¶¶ 1, 44–49; ECF No. 40 p. 1.) AIG seeks to disclaim coverage for the Remediation Costs under an insurance agreement issued to the Fisher Entities (Policy). (ECF No. 32 ¶ 1.) Conversely, the Fisher Entities seek coverage under the Policy for the Remediation Costs. (ECF No. 37 p. 19 ¶ 3.) The Policy, bearing policy number PLS 11057730, incepted on February 1, 2016 and expired on February 1, 2019. (Id. ¶ 53.) The Fisher Entities submitted to AIG a notice of claim as to the Remediation Costs on January 31, 2019. (Id. ¶ 69.) The Facility is an “Insured Property” under Endorsement No. 1 of the Policy. (Id. ¶ 60.) I. AIG’S AMENDED COMPLAINT AIG disputes coverage under the Policy on the following grounds: (1) the Fisher Entities failed to provide notice of the pollution conditions and claims “as soon as possible”; (2) the Fisher Entities failed to disclose the pollution conditions

2 This figure is comprised of: (1) $5,215,000 for the construction of a 1,200 square- foot treatment facility to accommodate upgrades to the treatment system at the Well Field (ECF No. 37 ¶¶ 50, 51); and (2) $14,291,000 to finance operations and maintenance activities over a remediation period of 30 years (id. ¶ 52). The Fisher Entities also agreed to pay the Borough about $484,000 for its water replacement costs, and $13,000 per month pending completion of upgrades to the treatment facility. (Id. ¶¶ 50–52.) in their insurance application to AIG3; (3) the Fisher Entities failed to cooperate with AIG in the investigation and defense of any claims against them, which deprived AIG of its right to control the defense of those claims; and (4) the Fisher Entities assumed obligations or made payments without AIG’s consent.4 (Id. ¶¶ 2, 3, 75.) The amended complaint asserts causes of action for declaratory relief (count one), and rescission for equitable fraud (count two). (Id. pp. 25, 26.) As to count one, AIG seeks a declaration that it has no obligation to indemnify the Fisher Entities for the Remediation Costs and any associated third-party claims. (Id. p. 3 ¶ 5.) Alternatively, as to count two, AIG seeks a judgment for rescission of the Policy. (Id.) II. THE FISHER ENTITIES’ ANSWER AND FIRST AMENDED COUNTERCLAIM. In their first amended counterclaim, the Fisher Entities contend the Remediation Costs are covered under the Policy. (ECF No. 37 p. 19 ¶ 3.) They also allege that AIG initially accepted coverage, then withdrew it one year later. (Id. p. 20 ¶ 5.) The Fisher Entities claim that this lawsuit is proceeding on “a now-abandoned coverage argument” and that AIG “filed this litigation without giving [the Fisher Entities] any meaningful opportunity to respond[.]” (Id. ¶ 6.) Purportedly, AIG’s conduct amounts to a “wrongful handling of [their] claims[.]” (Id. ¶ 7.) The Fisher Entities equate such conduct to bad faith. The first amended counterclaim describes the content of certain letters exchanged between AIG and the Fisher Entities. Specifically, AIG issued letters

3 AIG specifically alleges that the Fisher Entities were aware of detections of 1,4- dioxane and certain contaminants in the per- and polyfluoroalkyl substances family of chemicals, but failed to disclose the contaminants in their Policy application. (Id. ¶¶ 3– 5.)

4 The first amended complaint elsewhere alleges that the “known loss/loss-in- progress” doctrine bars coverage since the legal liability of the Fisher Entities “has been determined, is certain to occur, or the loss is already in progress.” (Id. ¶ 75(5).) to Thermo Fisher Scientific Inc. (Thermo Fisher) on March 15, 2019 (March 15 Letter) and March 28, 2019 (March 28 Letter) in response to Thermo Fisher’s notice of claim. (Id. ¶¶ 68, 70.) The March 15 Letter concerned claims pertaining to perfluorooctanoic acid and perfluorooctanesulfonic acid at the Fair Lawn Well Field Site, which encompasses the Well Field, and “reserve[d] [AIG’s] right to provide coverage for this matter subject to the Policy terms and conditions, [and] reservation of rights[.]” (Id. ¶¶ 18, 68.) Similarly, the March 28 Letter concerned claims pertaining to 1,4-dioxane, but “acknowledged that those claims were covered by the Policy … subject to the Policy terms and conditions, [and] reservation of rights[.]” (Id. ¶ 70.) Subsequently, by two letters dated May 18, 2020, AIG “implicitly withdrew its acceptance of coverage of [Thermo Fisher]’s 1,4-dioxane claims[.]” (Id. ¶ 83.) The Fisher Entities allege that neither the March 15 Letter nor the March 28 Letter “reserved rights with respect to any of the Policy provisions raised in [AIG]’s Complaint initiating this litigation[.]” (Id. ¶ 72.) The first amended counterclaim asserts the following causes of action: breach of contract (count one); breach of the implied covenant of good faith and fair dealing (count two); declaratory relief (count three); and equitable estoppel (count four). (Id. pp. 41, 43.) As a result of AIG’s alleged bad faith, the Fisher Entities claim they have been “deprived of the benefits of insurance coverage[.]” (Id. ¶ 124.) The Fisher Entities specifically allege that AIG committed bad faith by: (a) unreasonably delaying its investigation, evaluation, and processing of the Fisher Entities’ claims; (b) failing to reimburse the Fisher Entities for the covered loss while simultaneously failing to deny coverage; (c) wrongfully misinterpreting an “Other Insurance” provision in a Policy endorsement as a basis for delaying indemnification of the Fisher Entities’ claims; (d) surreptitiously withdrawing acceptance of coverage; (e) initiating this lawsuit without providing an opportunity to respond to AIG’s causes of action; and (f) misrepresenting the Fisher Entities’ disclosures to AIG during the Policy underwriting process to rescind the Policy. (Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pickett v. Lloyd's
621 A.2d 445 (Supreme Court of New Jersey, 1993)
Flomerfelt v. Cardiello
997 A.2d 991 (Supreme Court of New Jersey, 2010)
Voorhees v. Preferred Mutual Insurance
607 A.2d 1255 (Supreme Court of New Jersey, 1992)
Walker Rogge, Inc. v. Chelsea Title & Guaranty Co.
562 A.2d 208 (Supreme Court of New Jersey, 1989)
Doto v. Russo
659 A.2d 1371 (Supreme Court of New Jersey, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
AIG SPECIALTY INSURANCE COMPANY v. THERMO FISHER SCIENTIFIC, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/aig-specialty-insurance-company-v-thermo-fisher-scientific-inc-njd-2021.